Cephalon, Inc.
Business Description
Cephalon, Inc. is an international biopharmaceutical company dedicated to the
discovery, development and marketing of innovative products to treat human diseases.
We currently focus our efforts in four core therapeutic areas: central nervous
system ("CNS") disorders, pain, oncology and addiction. In addition
to conducting an active research and development program, we market seven proprietary
products in the United States and numerous products in various countries throughout
Europe. Consistent with our core therapeutic areas, we have aligned our approximately
690-person U.S. field sales and sales management teams by area. In Europe, we
have a sales and marketing organization numbering approximately 400 persons that
supports our presence in nearly 20 European countries, including France, the United
Kingdom, Germany, Italy and Spain.
|
